eFFECTOR and Quantitative Biosciences Institute (QBI) at UCSF Receive $5.0 Million from DARPA to Evaluate Zotatifin in COVID-19 Read more
HDT Bio, Gennova Biopharmaceuticals Announce First Healthy Volunteers Dosed in Phase I/II Trials Of Unique COVID-19 RNA Vaccine in India Read more
Vivace Therapeutics announces dosing of first cohort of patients with its first-in-class TEAD inhibitor Read more
Moderna Announces Supply Agreement with Gavi for up to 500 Million Doses of COVID-19 Vaccine Moderna for COVAX To Help End COVID-19 Pandemic in Lowest Income Countries Read more
New Data from Vaxart Oral COVID-19 Vaccine Phase I Study Suggests Broad Cross-Reactivity against Other Coronaviruses Read more
Enteris BioPharma Completes Expansion of Manufacturing Facility and Announces Launch of CDMO Business Segment Read more
Revive Therapeutics Enters Into Research Agreement with UCSF For Bucillamine As Potential Treatment For Severe COVID-19 Read more
Hoth Therapeutics Announces Development of HT-KIT to Treat Multiple Orphan Diseases, Including Rare Cancers Read more